Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Some medications can assist with weight management and may also reduce visceral fat. For example, a 2021 study of 140 adults found that 2.4 milligrams (mg) of semaglutide resulted in a 19.3% ...

Researchers chose to investigate semaglutide as a potential treatment because this class of drug has previously been shown to reduce fat and liver scarring for people with MASH. Between 2021 and ...

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

Researchers chose to investigate semaglutide as a potential treatment because this class of drug helps reduce fat and liver scarring for people with MASH. Previous smaller but positive studies by ...

The ultimate goal for researchers in the ESSENCE trial is to find the right balance of semaglutide to resolve the damage caused by the fat buildup in the liver (steatohepatitis) while at the same time ...

Professor Grace McComsey of Case Western Reserve University in Ohio and colleagues assessed the effects of semaglutide among HIV-positive people with lipohypertrophy, or abnormal fat accumulation.

“The results from this landmark study across 37 countries provide strong evidence that semaglutide can help patients with MASH by not only improving liver health, but also addressing the ...

Researchers chose to investigate semaglutide as a potential treatment because this class of drug has previously been shown to reduce fat and liver scarring for people with MASH. Between 2021 and ...